论文部分内容阅读
直肠癌辅助治疗观念的提出是基于手术后局部失败率较高。通过术前、术后的放疗或加化疗来提高保肛率、减少复发、提高生存率是近年研究的焦点,对T3期的病人建议采用术前联合治疗、手术加术后以5鄄Fu为基础的化疗。术前放疗建议按照常规剂量,放疗后4～8周行手术治疗。术后是否行辅助治疗应取决于病理分期,术后辅助治疗方案的选择建议以5鄄Fu为基础,加用LV、或Capecitabine、或Oxaliplatin、或CPT鄄11伴随放疗的临床研究正在进行中。
The concept of adjuvant treatment of rectal cancer is based on the higher rate of local failure after surgery. Preoperative and postoperative radiotherapy or chemotherapy to improve the rate of anus, reduce recurrence and improve survival rate is the focus of research in recent years, the T3 phase of the patient recommended the use of preoperative combination of surgery plus 5 Juan Fu Basic chemotherapy. Preoperative radiotherapy recommendations in accordance with the conventional dose, radiotherapy 4 to 8 weeks after surgery. Postoperative adjuvant therapy should be based on the pathological stage, the choice of postoperative adjuvant therapy regimen based on 5-Fu, plus LV, or Capecitabine, or Oxaliplatin, or CPT Juan 11 with radiotherapy clinical studies are underway.